NASDAQ:VNDA - Nasdaq - US9216591084 - Common Stock - Currency: USD
VNDA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 560 industry peers in the Biotechnology industry. VNDA has a medium profitability rating, but doesn't score so well on its financial health evaluation. VNDA has a expensive valuation and it also scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -7% | ||
ROE | -8.65% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 94.34% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.01 | ||
Debt/FCF | N/A | ||
Altman-Z | 1.46 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 3.93 | ||
Quick Ratio | 3.91 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
4.74
-0.25 (-5.01%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 1.39 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.55 | ||
P/tB | 0.7 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -7% | ||
ROE | -8.65% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 94.34% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.01 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 11.65% | ||
Cap/Sales | 0.46% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 3.93 | ||
Quick Ratio | 3.91 | ||
Altman-Z | 1.46 |